{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:32:26Z","timestamp":1791919946885,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the national key special fund for science and technology during the 13th five-year plan period","award":["2018zx10715-005"],"award-info":[{"award-number":["2018zx10715-005"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["(81672000"],"award-info":[{"award-number":["(81672000"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite the profound impact of antiretroviral therapy in the control of AIDS mortality, central nervous system opportunistic infections remains a significant burden in AIDS patients. This retrospective study aims to elucidate the clinical characteristics, outcome and risk factors of cryptococcal meningitis (CM) poor prognosis in AIDS patients from a tertiary hospital in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data from 128 patients admitted in Beijing Ditan Hospital, Capital Medical University from November 2008 to November 2017 was collected. The cohort was stratified based on treatment outcome (effective 79%, and ineffective 21%), and Multivariate Logistic regression analysis used to identify risk factors of poor disease prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Age, incidence of cerebral infarction, the proportion of consciousness disorder, and fasting plasma glucose was higher in the ineffective treatment group than the effective treatment group. The duration of treatment in the induction period of the ineffective group was significantly shorter than that of the effective group. Multivariate Logistic regression analysis indicated that the occurrence of cerebral hernia and consciousness disorder were risk factors for the prognosis of AIDS patients with CM infection, while the duration of treatment in the induction period was a indicative of a better prognosis in AIDS with CM infection complications. Finally, shunt decompression therapy correlated with a better disease outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This retrospective study exposes the main risk factors associated with worse disease prognosis in AIDS patients with CM infection complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05661-9","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T08:04:14Z","timestamp":1606809854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The clinical characteristics and outcome of cryptococcal meningitis with AIDS in a tertiary hospital in China: an observational cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Liang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiju","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"issue":"11","key":"5661_CR1","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrneurol.2016.149","volume":"12","author":"LN Bowen","year":"2016","unstructured":"Bowen LN, Smith B, Reich D, et al. HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment. Nat Rev Neurol. 2016;12(11):662\u201374.","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"5661_CR2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/cid\/ciu937","volume":"60","author":"J McKenney","year":"2015","unstructured":"McKenney J, Bauman S, Neary B, et al. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986\u20132012. Clin Infect Dis. 2015;60(6):959\u201365.","journal-title":"Clin Infect Dis"},{"key":"5661_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijid.2020.03.068","volume":"95","author":"H Yang","year":"2020","unstructured":"Yang H, Yin F, Xiao T, et al. A correlation analysis between clinical manifestations, therapeutic strategies, and the prognosis of children with cryptococcal meningitis in China. Int J Infect Dis. 2020;95:241\u20135.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"5661_CR4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/QAD.0b013e32832605fe","volume":"23","author":"T Bicanic","year":"2009","unstructured":"Bicanic T, Brouwer AE, Meintjes G, et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS (London, England). 2009;23(6):701\u20136.","journal-title":"AIDS (London, England)"},{"issue":"4","key":"5661_CR5","first-page":"397","volume":"17","author":"YQ Lu","year":"2018","unstructured":"Lu YQ, Huang XJ, Wu YS, et al. A retrospective study on prognostic factors of cryptococcal meningitis in 203 patients with acquired immunodeficiency syndrome. Chin J Neuromed. 2018;17(4):397\u2013401 (in Chinese with English abstract).","journal-title":"Chin J Neuromed"},{"key":"5661_CR6","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.3389\/fmicb.2019.02082","volume":"10","author":"L Xu","year":"2019","unstructured":"Xu L, Tao R, Wu J, et al. Short-course rather than low-dose amphotericin B may exert potential influence on mortality in Cryptococcal meningitis patients treated with amphotericin B plus Flucytosine alone or in combination with fluconazole. Front Microbiol. 2019;10:2082.","journal-title":"Front Microbiol"},{"issue":"12","key":"5661_CR7","first-page":"867","volume":"57","author":"Chinese center for disease control and prevention","year":"2018","unstructured":"Chinese center for disease control and prevention. Chinese guidelines for diagnosis and treatment of HIV\/AIDS (2018). Zhonghua Nei Ke Za Zhi. 2018;57(12):867\u201384.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"5","key":"5661_CR8","first-page":"317","volume":"57","author":"Chinese association of infectious diseases","year":"2018","unstructured":"Chinese association of infectious diseases. Expert consensus on the diagnosis and treatment of cryptococcal meningitis. Zhonghua Nei Ke Za Zhi. 2018;57(5):317\u201323.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"16","key":"5661_CR9","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1097\/QAD.0b013e3282a4a64d","volume":"21","author":"JN Jarvis","year":"2007","unstructured":"Jarvis JN, Harrison TS. HIV-associated cryptococcal meningitis. AIDS (London, England). 2007;21(16):2119\u201329.","journal-title":"AIDS (London, England)"},{"issue":"5","key":"5661_CR10","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/cid\/cit794","volume":"58","author":"JN Jarvis","year":"2014","unstructured":"Jarvis JN, Bicanic T, Loyse A, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis. 2014;58(5):736\u201345.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5661_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1136\/jclinpath-2014-202790","volume":"69","author":"AO Ogundeji","year":"2016","unstructured":"Ogundeji AO, Albertyn J, Pohl CH, et al. Method for identification of Cryptococcus neoformans and Cryptococcus gattii useful in resource-limited settings. J Clin Pathol. 2016;69(4):352\u20137.","journal-title":"J Clin Pathol"},{"issue":"3","key":"5661_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010;50(3):291\u2013322.","journal-title":"Clin Infect Dis"},{"key":"5661_CR13","first-page":"D9012","volume":"2","author":"B Njei","year":"2013","unstructured":"Njei B, Kongnyuy EJ, Kumar S, et al. Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis. Cochrane Database Syst Rev. 2013;2:D9012.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"5661_CR14","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/myc.12977","volume":"62","author":"X Wu","year":"2019","unstructured":"Wu X, Shen Y. Management of human immunodeficiency virus-associated cryptococcal meningitis: current status and future directions. Mycoses. 2019;62(10):874\u201382.","journal-title":"Mycoses."},{"key":"5661_CR15","first-page":"D5647","volume":"7","author":"MW Tenforde","year":"2018","unstructured":"Tenforde MW, Shapiro AE, Rouse B, et al. Treatment for HIV-associated cryptococcal meningitis. Cochrane Database Syst Rev. 2018;7:D5647.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"5661_CR16","first-page":"293","volume":"30","author":"Y Yan","year":"2012","unstructured":"Yan Y, Mai L, Xu WX, et al. The 10-year clinical analysis of cryptococcal meningitis treated with flueonazole and flucytosine. Chin J Infect Dis. 2012;30(5):293\u20136 (in Chinese with English abstract).","journal-title":"Chin J Infect Dis"},{"issue":"11","key":"5661_CR17","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","volume":"378","author":"SF Molloy","year":"2018","unstructured":"Molloy SF, Kanyama C, Heyderman RS, et al. Antifungal combinations for treatment of Cryptococcal meningitis in Africa. N Engl J Med. 2018;378(11):1004\u201317.","journal-title":"N Engl J Med"},{"key":"5661_CR18","volume-title":"Guidelines for the diagnosis, prevention and Management of Cryptococcal Disease in HIV-infected adults, adolescents and children: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Guidelines for the diagnosis, prevention and Management of Cryptococcal Disease in HIV-infected adults, adolescents and children: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: WHO; 2018."},{"issue":"1","key":"5661_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12883-017-0934-y","volume":"17","author":"Y Shimoda","year":"2017","unstructured":"Shimoda Y, Ohtomo S, Arai H, et al. Subarachnoid small vein occlusion due to inflammatory fibrosis-a possible mechanism for cerebellar infarction in cryptococcal meningoencephalitis: a case report. BMC Neurol. 2017;17(1):157.","journal-title":"BMC Neurol"},{"issue":"5","key":"5661_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/infdis\/jix033","volume":"215","author":"S Lofgren","year":"2017","unstructured":"Lofgren S, Hullsiek KH, Morawski BM, et al. Differences in immunologic factors among patients presenting with altered mental status during Cryptococcal meningitis. J Infect Dis. 2017;215(5):693\u20137.","journal-title":"J Infect Dis"},{"issue":"6","key":"5661_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.5582\/bst.2014.01070","volume":"8","author":"L Liu","year":"2014","unstructured":"Liu L, Zhang R, Tang Y, et al. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension in patients with HIV-associated cryptococcal meningitis with or without hydrocephalus. Biosci Trends. 2014;8(6):327\u201332.","journal-title":"Biosci Trends"},{"issue":"1","key":"5661_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3171\/2015.4.JNS15255","volume":"125","author":"J Cherian","year":"2016","unstructured":"Cherian J, Atmar RL, Gopinath SP. Shunting in cryptococcal meningitis. J Neurosurg. 2016;125(1):177\u201386.","journal-title":"J Neurosurg"},{"issue":"6","key":"5661_CR23","doi-asserted-by":"publisher","first-page":"z241","DOI":"10.1093\/ofid\/ofz241","volume":"6","author":"JW Baddley","year":"2019","unstructured":"Baddley JW, Thompson GR, Riley KO, et al. Factors associated with Ventriculoperitoneal shunt placement in patients with Cryptococcal meningitis. Open Forum Infect Dis. 2019;6(6):z241.","journal-title":"Open Forum Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05661-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05661-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05661-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T22:15:25Z","timestamp":1618524925000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05661-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5661"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05661-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-40106\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-40900\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-40900\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-40900\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"7 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was carried out in Beijing Ditan Hospital, Capital Medical University, and the study protocol was approved by the research ethics committee of hospital, which complied with principles of Declaration of Helsinki, and informed consent was waived due to anonymously used electronic medical records by the institutional review board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All of clinical and laboratory data were used anonymously. Consent for publication is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declared that there are no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"912"}}